SCHEMBL7236407

SCHEMBL7236407

CC(=O)N1CCC(CCCC(=O)c2ccc3c(c2)CNCCC3)CC1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.62
MCHR1 Q99705 12/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7227178 0.94 ACHE (0.69) ACHEMCHR1
SCHEMBL7226995 0.88 ACHE (0.59) ACHEMCHR1
SCHEMBL7228414 0.83 MCHR1 (0.56) ACHEMCHR1
Hydrochloric Acid SCHEMBL7229442 0.82 MCHR1 (0.56) ACHEMCHR1
SCHEMBL7227360 0.82 MCHR1 (0.59) ACHEMCHR1
SCHEMBL7226191 0.81 MCHR1 (0.51) ACHEMCHR1
SCHEMBL7226175 0.81 ACHE (0.67) ACHEMCHR1
SCHEMBL7227822 0.79 MCHR1 (0.55) ACHEMCHR1
SCHEMBL7227973 0.79 ACHE (0.46) ACHEMCHR1
Hydrochloric Acid SCHEMBL9210231 0.79 ACHE (0.68) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534496-B1 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2003-03-18 US disclosed